Tag: Cancer: Cervical
Sexual Minority Status Linked to Lower Odds of Pap Screen
Odds of ever undergoing pap testing lower for non-Hispanic White and Hispanic SM participants versus non-Hispanic White heterosexuals
Patient-Reported Outcomes + Wearable Data Predict Postop Adverse Events
Findings seen among women with gynecologic cancers followed for four weeks
Cemiplimab Prolongs Survival in Recurrent Cervical Cancer
Overall survival longer with cemiplimab versus single-agent chemo for recurrent disease after first-line platinum-containing chemo
Adverse Pregnancy Outcomes Reported for Women Diagnosed With CIN 3
Risk differences for all outcomes were attenuated over time; risk for early neonatal death disappeared
2005 to 2019 Saw Decline in Cervical Cancer Screening Rates
Most commonly cited reason for not receiving a timely screening was lack of knowledge
Cervical Cancer Incidence Varies by Neighborhood Wealth
Poorest neighborhoods in New York City have cervical cancer rates 73 percent higher than wealthiest neighborhoods
Cervical Cancer Deaths Down Following HPV Vaccine Introduction
Reductions in cervical cancer incidence, mortality in the U.S. greater for those aged 15 to 24 years than those aged 25 to 29, 30 to 39 years
Adding Pembrolizumab to Chemo Ups Survival in Cervical Cancer
Progression-free and overall survival significantly longer for patients with persistent, recurrent, metastatic cervical cancer
Globally, Cervical Cancer Incidence, Mortality Stable or Decreasing
Negative correlations seen for cervical cancer incidence and mortality rates with the Human Development Index
Unmet Social Needs, Distress Linked in Gynecologic Oncology Patients
Social isolation and lack of safety at home associated with distress; unmet needs also linked to treatment interruption
